| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |